In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cipla USA Inc.

Division of Cipla Ltd.
www.ciplausa.com

Latest From Cipla USA Inc.

Medicare New Technology Add-On Payment Awards For Hospital Drugs On The Rise

Eight inpatient prescription drugs are deemed eligible for supplemental payments in 2020, a big increase from years past, based on a review of US Medicare's new technology add-on payment approvals for prescription drugs since 2011. 

Medicare Reimbursement

The Quality Lowdown: Deferred Expire Dates, Broadened Import Alerts, Recall Roundup

The US FDA makes it easier for local agencies to extend expiration dates for doxycyline used in emergency situations; more drug quality updates in this week's lowdown.

Manufacturing Quality

Cipla, Piramal Launch Sensipar Generics Amid Growing Antitrust Challenges to Amgen/Teva Settlement

Amgen seeks a preliminary injunction to halt US sales by Cipla and says it will take steps to stop Piramal’s sales; in its antitrust lawsuit, Cipla alleges Amgen paid to license Teva products under the companies’ patent settlement, which resulted in Teva pulling its generic off the market shortly after launch.


Generic Drugs Launches

Final Generic Abuse-Deterrent Opioids Guidance Coming This Year

US FDA says it expects to finalize guidance by November, but more research is needed with generic development questions lingering.

Drug Approval Standards Generic Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cipla Ltd.
  • Senior Management
  • Tim Crew, CEO, North America, Dir.
  • Contact Info
  • Cipla USA Inc.
    Phone: (954) 793-4700
    1560 Sawgrass Corporate Pkwy.
    Ste. 130
    Sunrise, FL 33323
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register